|
The
Business & Commerce Excellence Jewel Award:
Azeem
Ibrahim of Ecmbank is
one of the UK's youngest and fastest-growing multi-millionaires. He
was inaugurated onto The Sunday Times Scots Rich List at the age of
just 31, with an estimated fortune of US$106 million. An outstanding
academic scholar, Azeem read for a PhD at the University of Cambridge
in Geopolitical Strategy. Since then, he has gained a comprehensive
understanding and passion for global markets that has made him one of
the most knowledgeable and skilled investment managers in the
industry. In fact, over the last couple of years, Azeem has met with
and advised a number of world leaders particularly those in the Gulf
States. Azeem is also the founding chairman of four UK based
charities which include a Bosnian student scholarship project and an
orphanage in Bangladesh. Azeem is now working to make all of these
projects self-sufficient.
Rajan
and Sanjay Kumar's Rajan Group imports and distributes
fashion clothing from its head office in Manchester, its warehouse in
the city and a branch office in London. It works on a contract basis
with blue chip high street stores, with much of the manufacturing
taking place abroad. It also produces its own branded clothes for
distribution through smaller retailers. Sanjay Kumar runs Rajan
Fashions with his brother Rajan. They have developed the business
from their father's market stall in Manchester to a supplier to top
fashion chains. The firm now has offices in New York and the Far East.
Dr
Rabinder Buttar, President and CEO of ClinTec
International Ltd was born in Punjab, India and brought
up in Scotland. She graduated from the Department of Bioscience &
Biotechnology, Strathclyde University in Glasgow in 1988 with a PhD
in Immunology and has been the President and CEO of the global
organisation, ClinTec International Ltd since the day she founded the
company in 1997. This company has major strategic offices throughout
the world and is now setting up its new headquarters in Glasgow with
a view to providing close support and work in partnership with
Scottish pharmaceutical and biotechnology companies in developing the
medicines of tomorrow. Through Rabinder's relentless efforts and
limitless energy, ClinTec International has acquired special
expertise in the field of cancer, having collaborated with major
Pharma companies in the successful conduct of numerous clinical
trials in this area. Information gained in the course of these trials
is already helping re-shape and improve the future of cancer therapy.
|
